Grzegorz Rymkiewicz
Curie Institute
86 Papers
178 Citations
Grzegorz Rymkiewicz is an academic researcher from Curie Institute. The author has contributed to research in topics: Lymphoma & Medicine. The author has an hindex of 21, co-authored 75 publications.
Chat about Author
Papers
Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders
Andy C. Rawstron,Alberto Orfao,Meral Beksac,Ludmila Bezdickova,Rik A. Brooimans,Horia Bumbea,Klara Dalva,Gwenny M. Fuhler,Jan W. Gratama,Dirk Hose,Lucie Kovarova,Michael Lioznov,Gema Mateo,Ricardo Morilla,Anne K. Mylin,Paola Omedè,Catherine Pellat-Deceunynck,Martin Perez Andres,Maria Teresa Petrucci,Marina Ruggeri,Grzegorz Rymkiewicz,Alexander Schmitz,Martin Schreder,Carine Seynaeve,Martin Spacek,Ruth M. de Tute,Els Van Valckenborgh,Nicola J. Weston-Bell,Roger G. Owen,Jesús F. San Miguel,Pieter Sonneveld,Hans Erik Johnsen +31 more
TL;DR: The primary clinical applications identified were: differential diagnosis of neoplastic plasma cell disorders from reactive plasmacytosis; identifying risk of progression in patients with MGUS and detecting minimal residual disease.
Differences in Risk Factors for Breast Cancer Molecular Subtypes in a Population-Based Study
Xiaohong R. Yang,Mark E. Sherman,David L. Rimm,Jolanta Lissowska,Louise A. Brinton,Beata Peplonska,Stephen M. Hewitt,William F. Anderson,Neonila Szeszenia-Dabrowska,Alicja Bardin-Mikolajczak,Witold Zatonski,Richard W. Cartun,Daniza Mandich,Grzegorz Rymkiewicz,Marcin Ligaj,Stanislaw Lukaszek,Radzisaw Kordek,Montserrat Garcia-Closas +17 more
TL;DR: Results from this study have shown that breast cancer risk factors may vary by molecular subtypes identified in expression studies, suggesting etiologic, in addition to clinical, heterogeneity of breast cancer.
504
Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network
Eva Hoster,Andreas Rosenwald,Françoise Berger,Heinz-Wolfram Bernd,Sylvia Hartmann,Christoph Loddenkemper,Thomas F. E. Barth,Nicole Brousse,Stefano Pileri,Grzegorz Rymkiewicz,Roman Kodet,Stephan Stilgenbauer,Roswitha Forstpointner,Catherine Thieblemont,Michael Hallek,Bertrand Coiffier,Ursula Vehling-Kaiser,Reda Bouabdallah,Lothar Kanz,Michael Pfreundschuh,Christian Schmidt,Vincent Ribrag,Wolfgang Hiddemann,Michael Unterhalt,Johanna Kluin-Nelemans,Olivier Hermine,Olivier Hermine,Martin Dreyling,Wolfram Klapper +28 more
TL;DR: Using the Ki-67 index is superior to using cytology and growth pattern as prognostic factors in MCL and shows a refined risk stratification, reflecting their strong complementary prognostic effects while integrating the most relevant prognostic Factors available in clinical routine.
314
A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma.
Itziar Salaverria,Itziar Salaverria,Idoia Martin-Guerrero,Idoia Martin-Guerrero,Rabea Wagener,Markus Kreuz,Christian W. Kohler,Julia Richter,Barbara Pienkowska-Grela,Patrick Adam,Birgit Burkhardt,Alexander Claviez,Christine Damm-Welk,Hans G. Drexler,Michael Hummel,Elaine S. Jaffe,Ralf Küppers,Christine Lefebvre,Jasmin Lisfeld,Markus Löffler,Roderick A. F. MacLeod,Inga Nagel,Ilske Oschlies,Maciej Rosolowski,Robert B. Russell,Grzegorz Rymkiewicz,Detlev Schindler,Matthias Schlesner,René Scholtysik,Carsten Schwaenen,Rainer Spang,Monika Szczepanowski,Lorenz Trümper,Inga Vater,Swen Wessendorf,Wolfram Klapper,Reiner Siebert +36 more
TL;DR: Findings indicate the existence of a molecularly distinct subset of B-cell lymphomas reminiscent of BL, which is characterized by deregulation of genes in 11q, which was shown to be mutated in 4 of 16 investigated cases.
217
CCND2 rearrangements are the most frequent genetic events in cyclin D1 mantle cell lymphoma
Itziar Salaverria,Itziar Salaverria,Cristina Royo,Alejandra Carvajal-Cuenca,Guillem Clot,Alba Navarro,Alejandra Valera,Joo Y. Song,Renata Woroniecka,Grzegorz Rymkiewicz,Wolfram Klapper,Elena Hartmann,Pierre Sujobert,Iwona Wlodarska,Judith A. Ferry,Philippe Gaulard,German Ott,Andreas Rosenwald,Armando López-Guillermo,Leticia Quintanilla-Martinez,Nancy L. Harris,Elaine S. Jaffe,Reiner Siebert,Elias Campo,Sílvia Beà +24 more
TL;DR: It is indicated that these tumors are clinically and biologically similar to the conventional cyclin D1(+) MCL and provides a basis for the proper identification and clinical management of these patients.
213